Consequently, increased DNA damage‐inducing p53 activity can lead to a decrease in IRS1 expression, alterations in IRS1 phosphorylation, and disruption of downstream insulin signaling pathways, ultimately contributing to insulin resistance.71, 72, 73, 74. The gene discussed is TP53; the disease is Insulin resistance.